tiprankstipranks
HAVN Life Sciences (HAVLF)
OTHER OTC:HAVLF
US Market
HAVLF
HAVN Life Sciences
RESEARCH TOOLSreports

HAVN Life Sciences (HAVLF) Financial Statements

32 Followers

HAVN Life Sciences Financial Overview

HAVN Life Sciences's market cap is currently $555.77K. The company's EPS TTM is $; its P/E ratio is ―; HAVN Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 21Apr 20
Income Statement
Total RevenueC$ 276.47KC$ 0.00
Gross ProfitC$ 89.69KC$ 0.00
Operating IncomeC$ -9.81MC$ -40.58K
EBITDAC$ -21.80MC$ -40.58K
Net IncomeC$ -22.44MC$ -40.58K
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.06MC$ 1.62M
Total AssetsC$ 4.06MC$ 1.94M
Total DebtC$ 389.35KC$ 0.00
Net DebtC$ -666.30KC$ -1.62M
Total LiabilitiesC$ 918.46KC$ 41.11K
Stockholders' EquityC$ 3.14MC$ 1.90M
Cash Flow
Free Cash FlowC$ -7.98MC$ -75.02K
Operating Cash FlowC$ -7.88MC$ -75.02K
Investing Cash FlowC$ -2.03MC$ -250.00K
Financing Cash FlowC$ 1.56MC$ 1.94M
Currency in CAD

HAVN Life Sciences Earnings and Revenue History

Income Statement >

HAVN Life Sciences Debt to Assets

Balance Sheet >

HAVN Life Sciences Cash Flow

Cash Flow >

HAVN Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >